David Shaw’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25M Buy
407,617
+72,100
+21% +$805K ﹤0.01% 2534
2026
Q1
$3.99M Buy
335,517
+32,928
+11% +$337K ﹤0.01% 2349
2025
Q4
$3.01M Buy
302,589
+36,094
+14% +$345K ﹤0.01% 2724
2025
Q3
$2.39M Buy
266,495
+27,860
+12% +$258K ﹤0.01% 2838
2025
Q2
$2.25M Sell
238,635
-142,881
-37% -$1.26M ﹤0.01% 2651
2025
Q1
$4.14M Buy
381,516
+175,926
+86% +$1.77M ﹤0.01% 2038
2024
Q4
$1.96M Sell
205,590
-297,292
-59% -$3.01M ﹤0.01% 2753
2024
Q3
$5.65M Sell
502,882
-14,934
-3% -$159K ﹤0.01% 1851
2024
Q2
$5.18M Buy
517,816
+13,384
+3% +$136K ﹤0.01% 1813
2024
Q1
$5.81M Buy
+504,432
New +$4.28M 0.01% 1777
2022
Q3
Sell
-241,152
Closed -$4.35M 5150
2022
Q2
$4.35M Buy
+241,152
New +$3.92M 0.01% 2298
2021
Q1
Sell
-38,621
Closed -$1.45M 4004
2020
Q4
$1.45M Buy
+38,621
New +$1.19M ﹤0.01% 2771

Other funds holding AHCO

David Shaw's AHCO Position: Q2 2026 in Review

David Shaw increased its AdaptHealth (AHCO) stake by 21% in Q2 2026, buying an estimated $805K and bringing the position to 407,617 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

David Shaw first reported a position in AHCO in Q4 2020 and has held it in 12 quarters since. The position peaked at $5.81M in Q1 2024. 237 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • David Shaw held 407,617 shares of AdaptHealth worth $4.25M as of Q2 2026.
  • David Shaw bought 72,100 AdaptHealth shares in Q2 2026, an estimated $805K.
  • AdaptHealth made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2534 holding.
  • David Shaw first reported a position in AdaptHealth in Q4 2020 and has held it in 12 quarters since.
  • David Shaw's AdaptHealth position peaked at $5.81M in Q1 2024.
  • 237 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.